GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » 3-Year FCF Growth Rate

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) 3-Year FCF Growth Rate : -25.60% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group 3-Year FCF Growth Rate?

CSPC Pharmaceutical Group's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.00.

During the past 12 months, CSPC Pharmaceutical Group's average Free Cash Flow per Share Growth Rate was -54.10% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -25.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 12.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of CSPC Pharmaceutical Group was 115.90% per year. The lowest was -51.90% per year. And the median was 23.90% per year.


Competitive Comparison of CSPC Pharmaceutical Group's 3-Year FCF Growth Rate

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 3-Year FCF Growth Rate falls into.



CSPC Pharmaceutical Group 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


CSPC Pharmaceutical Group  (OTCPK:CHJTF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


CSPC Pharmaceutical Group 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan 07-29-2014